"research and development expenses decreased by 8.5% to A$12.65 million"
Yet general expenses (wages, photocopier haha) huge increase
I would have thought R&D (bread and butter and core function of a clinical stage bio) would have increased with the five IP products, four of them at clinical trials ??
Analysts Reports (Imugene), page-302
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(2.83%) |
Mkt cap ! $383.0M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.1¢ | $854.9K | 16.43M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 5765446 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 2256872 | 24 |
View Market Depth
| Last trade - 14.07pm 12/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |